We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 362 results
  1. Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge

    Ribavirin ampoule formulation remains a major challenge in managing Lassa fever disease. Lassa fever is an endemic viral hemorrhagic fever in the...

    Qudus Olajide Lawal, Joseph Okoeguale, ... Sylvanus Akhalufo Okogbenin in Tropical Medicine and Health
    Article Open access 08 July 2024
  2. Analysing the association between perceived knowledge, and attitudes on Lassa Fever infections and mortality risk factors in lower Bambara Chiefdom

    Background

    Lassa fever (LF) presents significant public health challenges in Sierra Leone, particularly in the Lower Bambara Chiefdom. This study aims...

    Abu-Bakarr S. Kamara, Andrew Moseray, ... Mohamed Kemoh Rogers in BMC Public Health
    Article Open access 24 June 2024
  3. Spatio-temporal spread and evolution of Lassa virus in West Africa

    Background

    Lassa fever is a hemorrhagic disease caused by Lassa virus (LASV), which has been classified by the World Health Organization as one of the...

    **a Wang, **anwei Ye, ... Junjie Yue in BMC Infectious Diseases
    Article Open access 14 March 2024
  4. The deuce-ace of Lassa Fever, Ebola virus disease and COVID-19 simultaneous infections and epidemics in West Africa: clinical and public health implications

    Globally, the prevailing COVID-19 pandemic has caused unprecedented clinical and public health concerns with increasing morbidity and mortality....

    Nnabueze Darlington Nnaji, Helen Onyeaka, ... Amarachukwu Anyogu in Tropical Medicine and Health
    Article Open access 30 December 2021
  5. Fatal case of newborn Lassa fever virus infection mimicking late onset neonatal sepsis: a case report from northern Nigeria

    Background

    Lassa fever is a zoonotic viral infection endemic to the West Africa countries. It is highly fatal during pregnancy and as such reports of...

    Taofik Oluwaseun Ogunkunle, Surajudeen Oyeleke Bello, ... Abdulazeez Imam in Infectious Diseases of Poverty
    Article Open access 10 August 2020
  6. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

    Background

    Large outbreaks of Lassa fever (LF) occur annually in Nigeria. The case fatality rate among hospitalised cases is ~ 20%. The antiviral drug...

    Nastassya L. Chandra, Hikaru Bolt, ... Chikwe Ihekweazu in BMC Infectious Diseases
    Article Open access 04 February 2021
  7. Viral Hemorrhagic Fevers in Pregnant Women and the Vaccine Landscape: Comparisons Between Yellow Fever, Ebola, and Lassa Fever

    Purpose of Review

    As research efforts have advanced to understand the pathophysiology of viral hemorrhagic fevers (VHF) and other epidemic viral...

    Carleigh B. Krubiner, David A. Schwartz in Current Tropical Medicine Reports
    Article 26 November 2019
  8. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019

    Background

    Edo State Surveillance Unit observed the emergence of a disease with “no clear-cut-diagnosis”, which affected peri-urban Local Government...

    E. Nwachukwu William, John Oladejo, ... Chikwe Ihekweazu in BMC Public Health
    Article Open access 30 August 2022
  9. Research Progress of Fever with Thrombocytopenia Syndrome

    Severe fever with thrombocytopenia syndrome (SFTS) is a new infectious disease first discovered in Ta-pieh Mountains in central China in 2009. It is...

    Ning Luo, Mengdie Li, ... Yibin Lu in Intensive Care Research
    Article Open access 23 March 2023
  10. A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries

    Background

    We sought to develop and test an objective scorecard-based system for assessing and categorizing available research sites in Lassa...

    Kolawole Salami, Nathalie Imbault, ... Nadia G. Tornieporth in Pilot and Feasibility Studies
    Article Open access 13 February 2020
  11. Emerging and Re-emerging Infections in Travellers

    This book provides essential information on the epidemiology, diagnosis and management of common and some rare infections in travellers. It will...

    Hakan Leblebicioglu, Nick Beeching, Eskild Petersen
    Book 2024
  12. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria

    Background

    Lassa fever (LF) is a zoonotic infectious disease of public concern in Nigeria. The infection dynamics of the disease is not well...

    Clement Ameh Yaro, Ezekiel Kogi, ... James Paul Oni in BMC Infectious Diseases
    Article Open access 05 February 2021
  13. A proposed One Health approach to control yellow fever outbreaks in Uganda

    Yellow Fever (YF) is an acute viral hemorrhagic disease. Uganda is located within the Africa YF belt. Between 2019 and 2022, the Ugandan Health...

    Emmanuel Angmorteh Mensah, Samuel Ofori Gyasi, ... Walid Q. Alali in One Health Outlook
    Article Open access 23 May 2024
  14. Clinical characteristics and aetiology of uveitis in a viral haemorrhagic fever zone

    Background/Objectives

    Studies on uveitis in Sierra Leone were conducted prior to the Ebola Virus Disease epidemic of 2013–16, which was associated...

    Shiama Balendra, Lloyd Harrison-Williams, ... Alasdair Kennedy in Eye
    Article Open access 15 May 2024
  15. Investigation of a cross-border case of Lassa fever in West Africa

    Background

    Infectious disease prevention and control strategies require a coordinated, transnational approach. To establish core capacities of the...

    Mory Keïta, Georges Alfred Kizerbo, ... Ibrahima Socé Fall in BMC Infectious Diseases
    Article Open access 10 July 2019
  16. Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review

    Background

    Lassa fever virus has been enlisted as a priority pathogen of epidemic potential by the World Health organization Research and Development...

    Noah Fongwen Takah, Polina Brangel, ... Rosanna Peeling in BMC Infectious Diseases
    Article Open access 19 July 2019
  17. Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: implications for risk communication

    Background

    Lassa fever (LF) is an epidemic-prone zoonotic disease prevalent in Nigeria and Ebonyi State is a high burden area in Nigeria. Low risk...

    Ifeoma Sophia Usuwa, Christian Obasi Akpa, ... Muhammad Shakir Balogun in BMC Public Health
    Article Open access 12 February 2020
  18. Lesson learned from the investigation and response of Lassa fever outbreak, Margibi County, Liberia, 2018: case report

    Background

    Lassa fever (LF) is a viral hemorrhagic disease caused by the Lassa virus (LASV) and endemic in West African countries with an estimation...

    Abyot Bekele Woyessa, Leroy Maximore, ... Nuha Mahmoud in BMC Infectious Diseases
    Article Open access 11 July 2019
  19. Projecting vaccine demand and impact for emerging zoonotic pathogens

    Background

    Despite large outbreaks in humans seeming improbable for a number of zoonotic pathogens, several pose a concern due to their...

    Anita Lerch, Quirine A. ten Bosch, ... Sean M. Moore in BMC Medicine
    Article Open access 16 June 2022
  20. Epidemiology and Genomic characteristics of arenavirus in rodents from the southeast coast of P.R. China

    Background

    Wenzhou virus (WENV), a member of the Mammarenavirus genus in the Arenaviridae family, has been detected in wild rodents from eight...

    Qinghua **e, Changqiang Zhu, ... Lingling Zhang in BMC Veterinary Research
    Article Open access 29 November 2023
Did you find what you were looking for? Share feedback.